Vivani Medical (Nasdaq:VANI) announced today that it plans to spin off Cortigent, a division that develops brain implants. The company wants to create two focused companies dedicated to driving current and future value in their respective therapeutic areas. Vivani aims to continue advancing its miniature GLP-1 therapeutic implants. The spin-off would enable Cortigent to continue […]
Mergers & Acquisitions
Henry Schein completes acquisition of CGM supplier Acentus
Henry Schein (Nasdaq: HSIC) announced today that it completed the acquisition of substantially all the assets of Acentus. Tampa, Florida-based Acentus, a national medical supplier, specializes in the delivery of continuous glucose monitors (CGMs). The company reports annual revenue of approximately $35 million. Melville, New York-based Henry Schein announced its agreement to acquire the company […]
Phillips Medisize enhances inhaled drug delivery portfolio with Vectura acquisition
Phillips Medisize parent company Molex announced today that it completed its acquisition of Vectura from a subsidiary of cigarette maker Philip Morris. The company says adding Vectura enables it to offer a wider range of formulation, device design, combination product development and manufacturing services. It acquires Vectura’s proprietary technology and combination product development expertise in dry […]
Boston Scientific to acquire hepatic artery infusion pump maker Intera Oncology
Boston Scientific (NYSE:BSX) announced today that it agreed to acquire infusion pump maker Intera Oncology for an undisclosed amount. Intera Oncology develops the Intera 3000 hepatic artery infusion pump and floxuridine, a chemotherapy drug. Both hold FDA approval. The pump administers hepatic artery infusion (HAI) therapy to treat tumors in the liver primarily caused by […]
Phillips Medisize to buy inhaled drug delivery device maker Vectura from Philip Morris
Phillips Medisize parent company Molex announced that it agreed to acquire Vectura from a subsidiary of cigarette maker Philip Morris. Vectura designs and develops devices and formulations for inhaled drug delivery. Philip Morris paid $1.2 billion for the UK-based company in 2021 as part of its “Beyond Nicotine” effort to phase out cigarettes and develop […]
Ypsomed closes pen needle, BGM business sale to focus on insulin pump
Ypsomed announced today that it completed the sale of its pen needle and blood glucose monitoring (BGM) businesses to Medical Technology and Devices (MTD). The Burgdorf, Switzerland-based company first announced an agreement to sell off those businesses to MTD in March. Ypsomed plans to support a reliable transition to ensure pen needle supply amid the […]
Embecta stock rises on reports that it might look to sell
Financial Times reports that Embecta (Nasdaq:EMBC), the former diabetes unit at BD, hired advisers to look into a possible sale of the company. Shares of EMBC ticked up 16.5% to $15.34 apiece in early-morning trading today. The company has operated as a standalone, publicly-traded company since April 2022, when it completed its spin-off from BD. […]
Why Abbott acquired Bigfoot Biomedical and its smart insulin pens
When Abbott (NYSE:ABT) acquired Bigfoot Biomedical in September 2023, it took the final step to build upon a multi-year relationship. The medtech giant had a long-term, vested interest in Bigfoot, a maker of a smart insulin management system. It dates back to 2017, with Abbott even leading a financing round for Bigfoot in 2020. “We […]
Surmodics to be acquired by private equity firm for $627M
Surmodics (Nasdaq:SRDX) announced today that it agreed to be acquired by GTCR, a private equity firm with healthcare interests. Eden Prairie, Minnesota-based Surmodics develops a range of technologies, including drug-coated balloons and thrombectomy systems. Its SurVeil DCB received a long-awaited FDA approval in June 2023. The company also reported successful early clinical use of its […]
Ypsomed sells pen needle, blood glucose monitor business to focus on insulin pump
Ypsomed announced today that it agreed to sell its pen needle and blood glucose monitoring (BGM) businesses to Medical Technology and Devices (MTD). With the transfer of these businesses, Ypsomed plans to focus its diabetes care business on insulin pumps. Specifically, it looks to the further development and marketing of the mylife Loop automated insulin […]
